Cite
APA Citation
Yang, X., Sen, F., & Geyer, M. B. (2019). inotuzumab ozogamicin as chemotherapy-sparing salvage in a 67-year-old man with primary refractory B-cell acute lymphoblastic leukemia with high-risk genomic features. Leukemia research reports, 12, . http://access.bl.uk/ark:/81055/vdc_100098052774.0x000010